+48%

est. 2Y upside i

HealthcareSeries B

Osmind is a San Francisco–based public benefit corporation led by scientists, technologists, and psychiatrists to advance new evidence-generating medicine that helps people living with moderate to severe mental health conditions.

Rank

#1007

Sector

HealthTech / Mental Health Software

Est. Liquidity

~3Y

Data Quality

Data: Medium

Joining Osmind offers a high-risk, moderate-upside opportunity.

Last updated: July 19, 2026

Bull (20%)+178%

Osmind capitalizes on FDA momentum and partnerships (Compass Pathways, LivaNova) to maintain a 7x revenue multiple, reaching $84M exit; after 20% dilution, upside of 178%.

Base (55%)+67%

Multiple converges to ~4x as company grows to ~$12M ARR, exit value ~$48M; net of 20% dilution, upside of 67%.

Bear (25%)-100%

Multiple compresses to 2x, exit value ~$24M; $57.2M preference stack leaves common stock worthless, resulting in -100% return.

Est. time to liquidity~3.0 years

Preference Stack Risk

severe

Funding Intensity

65700%

Total funding of $57.2M exceeds current valuation of $26.1M, so common stock is entirely subordinate; exit must exceed $57.2M for any common value.

Dilution Risk

high

With no cash position given and 4+ years since last round, the company likely needs to raise again within 24 months, causing 15-25% dilution.

Secondary Liquidity

none

No secondary market activity or implied valuation is available; the analyst estimate is the only benchmark.

Other — 2 roles

View all 2 open roles at Osmind →

Last updated: March 10, 2026

Questions to Ask at the Interview

Strategic questions based on Osmind's data — designed to show you've done your homework.

  • 1

    “How does Osmind plan to defend against larger EHR incumbents like NextGen or AdvancedMD entering the interventional psychiatry niche?”

  • 2

    “What is the unit economics of a typical practice customer, and how does the path to profitability look given the high preference stack?”

  • 3

    “Given the 2022 Series B and stale valuation, what is the expected timeline for a liquidity event, and how does the current equity grant reflect the risk?”

Community

Valuation Sentiment

Our model estimates +48% upside. What do you think?

Anonymous. Do not share material non-public information.

Community Discussion

Comments are reviewed before they appear publicly.

0/2000

Loading comments...

Disclaimer: This analysis is AI-generated and does not constitute financial or career advice. Always conduct your own due diligence.